Aurora Cannabis (ACB) Invested Capital (2018 - 2025)

Aurora Cannabis (ACB) has reported Invested Capital for 8 consecutive years, with $479.6 million the latest figure, recorded in Q4 2025.

• Quarterly Invested Capital fell 32.77% year-over-year to $479.6 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $84.8 million (down 82.95% YoY) and the FY2025 annual result came in at $513.0 million, down 27.4% from the prior year.
• Invested Capital eased to $479.6 million in Q4 2025 per ACB's latest filing, from $485.0 million in the prior quarter.
• Over the last five years, Invested Capital for ACB reached as high as $2.1 billion in Q1 2021 and fell as low as $177632.0 in Q1 2022.
• A 5-year average of $459.1 million and a median of $491.0 million in 2025 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2022 — Invested Capital sank 99.99% — and 2023, when it soared 15817.27%.
• Year by year, Invested Capital stood at $180087.3 in 2021, then surged by 7666.4% to $14.0 million in 2022, then soared by 4629.84% to $661.5 million in 2023, then grew by 7.84% to $713.4 million in 2024, then slumped by 32.77% to $479.6 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $479.6 million, $485.0 million, and $498.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.